X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs BIOCON - Comparison Results

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB BIOCON UNICHEM LAB/
BIOCON
 
P/E (TTM) x 280.1 40.7 688.5% View Chart
P/BV x 0.6 7.1 9.1% View Chart
Dividend Yield % 2.6 0.2 1,604.8%  

Financials

 UNICHEM LAB   BIOCON
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
BIOCON
Mar-18
UNICHEM LAB/
BIOCON
5-Yr Chart
Click to enlarge
High Rs3821,188 32.2%   
Low Rs234305 76.8%   
Sales per share (Unadj.) Rs116.368.7 169.2%  
Earnings per share (Unadj.) Rs-18.97.6 -250.6%  
Cash flow per share (Unadj.) Rs-11.714.0 -84.0%  
Dividends per share (Unadj.) Rs5.001.00 500.0%  
Dividend yield (eoy) %1.60.1 1,211.7%  
Book value per share (Unadj.) Rs381.086.3 441.3%  
Shares outstanding (eoy) m70.34600.00 11.7%   
Bonus/Rights/Conversions BBIS-  
Price / Sales ratio x2.610.9 24.4%   
Avg P/E ratio x-16.398.9 -16.5%  
P/CF ratio (eoy) x-26.253.4 -49.1%  
Price / Book Value ratio x0.88.6 9.4%  
Dividend payout %-26.413.2 -199.6%   
Avg Mkt Cap Rs m21,668447,900 4.8%   
No. of employees `0002.36.1 37.1%   
Total wages/salary Rs m2,0069,311 21.5%   
Avg. sales/employee Rs Th3,587.86,705.8 53.5%   
Avg. wages/employee Rs Th880.01,514.2 58.1%   
Avg. net profit/employee Rs Th-583.7736.9 -79.2%   
INCOME DATA
Net Sales Rs m8,18041,234 19.8%  
Other income Rs m6102,062 29.6%   
Total revenues Rs m8,79043,296 20.3%   
Gross profit Rs m-1,3208,291 -15.9%  
Depreciation Rs m5053,851 13.1%   
Interest Rs m80615 13.0%   
Profit before tax Rs m-1,2955,887 -22.0%   
Minority Interest Rs m0213 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m331,569 2.1%   
Profit after tax Rs m-1,3314,531 -29.4%  
Gross profit margin %-16.120.1 -80.3%  
Effective tax rate %-2.626.7 -9.7%   
Net profit margin %-16.311.0 -148.1%  
BALANCE SHEET DATA
Current assets Rs m23,31841,486 56.2%   
Current liabilities Rs m4,63521,413 21.6%   
Net working cap to sales %228.448.7 469.2%  
Current ratio x5.01.9 259.7%  
Inventory Days Days12264 190.4%  
Debtors Days Days12194 129.0%  
Net fixed assets Rs m8,16350,661 16.1%   
Share capital Rs m1413,000 4.7%   
"Free" reserves Rs m26,66048,808 54.6%   
Net worth Rs m26,80151,808 51.7%   
Long term debt Rs m317,898 0.0%   
Total assets Rs m31,89099,897 31.9%  
Interest coverage x-15.210.6 -143.5%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.30.4 62.1%   
Return on assets %-3.95.2 -76.1%  
Return on equity %-5.08.7 -56.8%  
Return on capital %-4.59.6 -47.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,35612,058 36.1%   
Fx outflow Rs m07,348 0.0%   
Net fx Rs m4,3564,710 92.5%   
CASH FLOW
From Operations Rs m-1,1236,621 -17.0%  
From Investments Rs m16,487-6,840 -241.0%  
From Financial Activity Rs m-8,811-2,397 367.6%  
Net Cashflow Rs m6,552-2,612 -250.8%  

Share Holding

Indian Promoters % 50.1 40.4 124.0%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 15.1 8.4 179.8%  
FIIs % 3.0 10.7 28.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 19.9 159.3%  
Shareholders   20,176 109,995 18.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   PIRAMAL ENTERPRISES  NOVARTIS  DR. DATSONS LABS  DR. REDDYS LAB  GSK PHARMA  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 222 Points Lower; Energy and Telecom Stocks Witness Selling(Closing)

Indian share markets witnessed most of the selling pressure during closing hours and ended their trading session lower.

Related Views on News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Mar 22, 2019 03:35 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS